Loading clinical trials...
Loading clinical trials...
This study is a randomized, placebo-controlled, single-masked (blinded), post-marketing clinical study of a drug Lactobacillus Reuteri NCIMB 30351 drops in functional disorders of gastrointestinal tra...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
NovoNatum Ltd
NCT07545772 · Irritable Bowel Syndrome, Constipation
NCT05588323 · Opioid-Induced Constipation (OIC)
NCT07215351 · Constipation, Bloating
NCT07202481 · Constipation - Functional
NCT07462481 · Constipation
Children's City Clinical Hospital named after Bashlyaeva, Healthcare department of Moscow city
Moscow
Medical Center "St. Andrew's Hospitals - NEBOLIT"
Moscow
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions